Protection against symptomatic disease with the delta and omicron BA.1/BA.2 variants of SARS-CoV-2 after infection and vaccination in adolescents: national observational test-negative case control study, August 2021 to March 2022, England
Annabel A Powell, Freja Kirsebom, Julia Stowe, Mary E Ramsay, Jamie Lopez-Bernal, Nick Andrews, Shamez N Ladhani
doi: https://doi.org/10.1101/2022.08.19.22278987
Annabel A Powell
1Public Health Programmes, UK Health Security, London, UK
Freja Kirsebom
1Public Health Programmes, UK Health Security, London, UK
Julia Stowe
1Public Health Programmes, UK Health Security, London, UK
Mary E Ramsay
1Public Health Programmes, UK Health Security, London, UK
Jamie Lopez-Bernal
1Public Health Programmes, UK Health Security, London, UK
2NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom
Nick Andrews
1Public Health Programmes, UK Health Security, London, UK
3NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, London, United Kingdom
Shamez N Ladhani
1Public Health Programmes, UK Health Security, London, UK
4Paediatric Infectious Diseases Research Group, St George’s University of London, London, UK
Data Availability
Applications for relevant anonymised data should be submitted to the UK Health Security Agency Office for Data Release: https://www.gov.uk/government/publications/accessing-ukhsa-protected-data/accessing-ukhsa-protected-data.
Posted August 22, 2022.
Protection against symptomatic disease with the delta and omicron BA.1/BA.2 variants of SARS-CoV-2 after infection and vaccination in adolescents: national observational test-negative case control study, August 2021 to March 2022, England
Annabel A Powell, Freja Kirsebom, Julia Stowe, Mary E Ramsay, Jamie Lopez-Bernal, Nick Andrews, Shamez N Ladhani
medRxiv 2022.08.19.22278987; doi: https://doi.org/10.1101/2022.08.19.22278987
Protection against symptomatic disease with the delta and omicron BA.1/BA.2 variants of SARS-CoV-2 after infection and vaccination in adolescents: national observational test-negative case control study, August 2021 to March 2022, England
Annabel A Powell, Freja Kirsebom, Julia Stowe, Mary E Ramsay, Jamie Lopez-Bernal, Nick Andrews, Shamez N Ladhani
medRxiv 2022.08.19.22278987; doi: https://doi.org/10.1101/2022.08.19.22278987
Subject Area
Subject Areas
- Addiction Medicine (324)
- Allergy and Immunology (627)
- Anesthesia (163)
- Cardiovascular Medicine (2373)
- Dermatology (206)
- Emergency Medicine (379)
- Epidemiology (11770)
- Forensic Medicine (10)
- Gastroenterology (702)
- Genetic and Genomic Medicine (3738)
- Geriatric Medicine (350)
- Health Economics (633)
- Health Informatics (2395)
- Health Policy (933)
- Hematology (341)
- HIV/AIDS (782)
- Medical Education (365)
- Medical Ethics (104)
- Nephrology (398)
- Neurology (3502)
- Nursing (198)
- Nutrition (525)
- Oncology (1823)
- Ophthalmology (537)
- Orthopedics (219)
- Otolaryngology (287)
- Pain Medicine (232)
- Palliative Medicine (66)
- Pathology (446)
- Pediatrics (1033)
- Primary Care Research (420)
- Public and Global Health (6139)
- Radiology and Imaging (1280)
- Respiratory Medicine (826)
- Rheumatology (379)
- Sports Medicine (323)
- Surgery (402)
- Toxicology (50)
- Transplantation (172)
- Urology (145)